Modules 1-3 Flashcards

1
Q

Who can report a potential adverse drug event to the FDA? (4 options)

A
  • physicians
  • drug manufacturers
  • patients
  • pharmacists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

TJC requires hospitals to perform which two surveillance programs?

A
  • Adverse Drug Reaction Monitoring
  • Drug Use Evaluation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complete the sentence:
Pharmacoepidemiology is the study of…

A

The effects of drugs on the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Post-marketing drug surveillance is completed to…

A

Identify unknown drug-related adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the BEST way that describes the different types of measurable drug effects looked at in pharmacoepidemiology?

A

Anticipated or unanticipated beneficial or harmful effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epidemiology Principles or Medication Use?

Pharmacokinetics

A

medication use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • Epidemiology Principles or Medication Use? -

Pharmacology

A

medication use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • Epidemiology Principles or Medication Use? -

pharmacodynamics

A

medication use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • Epidemiology Principles or Medication Use? -

Distribution of diseases in populations

A

epidemiology principles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Post-marketing drug surveillance is completed to:

A

identify unknown drug-related adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Efficacy, effectiveness, or efficiency?
Studied in a RCT under perfect conditions

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Efficacy, effectiveness, or efficiency?
In the real-world can a drug achieve its desire effect?

A

effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Efficacy, effectiveness, or efficiency?
Whether the drug has the ability to bring about intended effect

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Efficacy, effectiveness, or efficiency?
Can the drug get the desired effect at an acceptable cost

A

efficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who can report a potential adverse drug event (ADE) to the U.S. Food & Drug Administration (FDA)?

A
  • patients
  • physicians
  • drug manufacturers
  • pharmacists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What can be a reason to conduct a pharmacoepidemiologic study?

A
  • mitigate risk
  • regulatory requirement
  • obtain a new drug indication
  • mitigate liability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pharmacoepidemiology has primarily concerned itself with study of of adverse drug effects

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which of the following is a risk evaluation tool for vaccines?

A

VAERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Part of the responsibility of clinical pharmacology is to provide a _________ assessment for the effect of drugs in patients

A

risk-benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which statement is correct about AE and ADR?

A
  • ADRs are a subset of AEs
  • AE does not necessarily have to have a causal relationship with the treatment
  • ADR generally has a causal relationship associated with the treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

REMS stands for…

A

Risk Evaluation and Mitigation Strategy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

TJC requires hospitals to maintain an adverse drug reaction monitoring program/drug use evaluation program

A

true

23
Q

How would you describe the pharmacist role in population-based interventions?

A
  • providing discharge counseling on new medication during transitions of care
  • Conversion of 30-day fills to 90-day fills to improve medication adherence and reduce costs
    -Participation at a health fair, screening for HTN and DM using risk-based tools
  • Developing and completing medication use evaluations
24
Q

Which of the following is the first step in implementing pharmacist-provided population health services?

A

conduct SWOT analysis

25
Q

By definition, community/retail pharmacy is traditionally not considered as a key component in transition of care management (TCM) when in actuality, community/retail pharmacy integration should be part of every TCM program

A

True

26
Q

….. which of the following pharmacists would you engage in developing a HF medication management program?
ambulatory care pharmacists? inpatient hospital pharmacists? Community/retail pharmacists?

A

all of the above

27
Q

Which of the following describes a value-proposition in pharmacists providing chronic care management?

A

increasing provider efficiency

28
Q

CMS MIPS weights

A

improved activities - 15%
quality - 30%
cost - 30%
promoting interoperability - 25%

29
Q

Quality measure were developed to ensure access to healthcare that is:

A

safe

30
Q

In what setting would a pharmacist apply principles of population health management to patient care?

A
  • primary care
  • hospital
  • community/retail pharmacy
  • ambulatory care
31
Q

Numerator or Denominator?
The target population of the measure

A

denominator

32
Q

Numerator or Denominator?
The measure of focus within a population

A

numerator

33
Q

Value-based care models focus on addressing healthcare quality goals and aims. Which of the following are examples of how these goals and aims are being met?

A
  • Community pharmacists administration of COVID-19 vaccines during the pandemic
  • Implementation of technology into the medication management processes
  • Reduction in the incidence of co-morbidities in patients with Type II Diabetes
34
Q

A model of a primary care organization that delivers the core function of primary health care than is comprehensive, patient-centered, coordinated, accessible, and of high quality and safety is know as…

A

PCMH

35
Q

JS is an 85 yo male pt being discharged from the hospital after a 3-day admission for fluid overload secondary to uncontrolled CHF. CO-morbidities include HLD, HTN, T2DM and CKD State 3b. JS is a patient that you have been following as the pharmacies in the Heart Failure Ambulatory Care Clinics. TO qualify for enhanced reimbursement by CMS, JS would need to be seen in the heart failure clinic within 14 days of the date of discharge from the hospital. T/F?

A

False
- would need to be a 7-day f/u visit as this would be considered HIGH complexity

36
Q

Pay-for-performance models are moving towards being more of a…

A

mixture of upside and downside approach

37
Q

The Institute of Healthcare Improvement’s (IHI) Triple Aim has been proposed to be changed to the Quadruple Aim by the addition of…

A

Improving the work life of healthcare providers

38
Q

A shared savings, or risk approach that provides incentive payments to providers who are part of a health care organization that reach pre-determined benchmarks for spending and quality of care is known as

A

Accountable Care Organization

39
Q

According to Teisberg, et. al., value aligns care with how patients experience their health and focuses on all of the following EXCEPT FOR

A

hospitality

40
Q

According to Teisberg, et. al., value aligns care with how patients experience their health and focuses on…

A
  • comfort
  • capability
  • calm
41
Q

New methods of pay for performance focus on an individual provider to produce change on improvements in quality of care delivered.
T/F?

A

False

42
Q

Legislation designed to transform the basis of healthcare clinician payment from volume to value is known as

A

MACRA

43
Q

HEDIS is administered and overseen by Centers for Medicaid Services (CMS)

A

False
- Established by National Committee for Quality Assurance (NCQA)

44
Q

A comprehensive set of standardize performance measures designed to provide purchaser and consumers with the information needed for reliable comparison of health plan performance is known as

A

HEDIS

45
Q

Low financial risk and degree of care provider integration and accountability

A
  • fee-for-service
  • primary care incentives
46
Q

high financial risk and degree of care provider integration and accountability

A
  • capitation + performance-based contracts
  • shared risk
47
Q

For a pharmacist to have an impact on the provision of value-based care, what is required?

A

pharmacists integration within inter-disciplinary health care teams

48
Q

the definition and view of quality is the same amongst key stakeholders in healthcare
T/F?

A

False

49
Q

What is the largest contribution to the rising healthcare costs?

A

clinical diversity

50
Q

The program that allows eligible clinicians to receive payment adjustments for the services they provide for medicare patients based on quality cost, improvement activities, and promotion and interoperability risk known as

A

MIPS

51
Q

Under MACRA’s Quality Payment Program (QPP), if a provider wanted to maximize incentive payments for providing high-quality, cost-effective care to their medicare patients, they would choose to participate in the Merit-based incentive payment system

A

False

52
Q

Pt-centered medical home (PCMH) is…

A

A model for the delivery of value-based care within primary care setting

53
Q

According to Teisberg, et. al., “value in health care is the measured improvement in a pt’s health outcome for the cost of achieving that improvement.” To provide value-based care a primary focus of a healthcare organization should be on reducing costs

A

False

54
Q

Program that enables providers and suppliers in healthcare to set up an accountable care organization (ACO) is known as…

A

MSSP